methamphetamine has been researched along with acetylcysteine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fukumoto, D; Hashimoto, K; Iyo, M; Kakiuchi, T; Nishiyama, S; Shimizu, E; Tsukada, H | 2 |
| Fukami, G; Hashimoto, K; Iyo, M; Koike, K; Okamura, N; Shimizu, E | 1 |
| Achat-Mendes, C; Anderson, KL; Itzhak, Y | 1 |
| Banerjee, A; Banks, WA; Ercal, N; Zhang, X | 1 |
| Banerjee, A; Banks, WA; Ercal, N; Manda, KR; Zhang, X | 1 |
| Grant, JE; Kim, SW; Odlaug, BL | 1 |
| Largeron, M; Martinez, CM; McCann, U; Mechan, A; Mueller, M; Neudörffer, A; Ricaurte, GA | 1 |
| Ercal, N; Tobwala, S; Zhang, X | 1 |
| Karimian Sichani, N; Maracy, M; Mousavi, SG; Peykanpour, M; Salehi, M; Sharbafchi, MR | 1 |
| Baker, AL; Berk, M; Carter, G; Dean, OM; Kelly, PJ; McKetin, R; Turner, A | 1 |
| Amaral, C; Bastos, ML; Carvalho, F; Carvalho, M; Correia-da-Silva, G; Duarte, JA; Guedes de Pinho, P; Valente, MJ | 1 |
| Bevins, RA; Charntikov, S; Pittenger, ST; Pudiak, CM | 1 |
| Huang, J; Li, J; Li, Q; Li, SB; Li, Z; Lu, G; Sham, PC; Wong, N; Yang, G; Zeng, XF | 1 |
| Arunogiri, S; Baker, AL; Bathish, R; Berk, M; Carter, G; Cordaro, F; Dean, OM; Dietze, P; Higgs, P; Hill, H; Kelly, PJ; Kent, M; Liang, W; Lubman, DI; Manning, V; McKetin, R; Quinn, B; Raftery, D; Reid, D; Sinclair, B; Te Pas, N; Thomas, T; Turner, A | 1 |
1 review(s) available for methamphetamine and acetylcysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for methamphetamine and acetylcysteine
| Article | Year |
|---|---|
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence.
Topics: Acetylcysteine; Adult; Amphetamine-Related Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Young Adult | 2010 |
The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Topics: Acetylcysteine; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Craving; Cross-Over Studies; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Methamphetamine; Substance Withdrawal Syndrome; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2015 |
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
Topics: Acetylcysteine; Adolescent; Adult; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Clinical Trials, Phase II as Topic; Craving; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Young Adult | 2019 |
14 other study(ies) available for methamphetamine and acetylcysteine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine.
Topics: Acetylcysteine; Animals; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Neuroprotective Agents; Positron-Emission Tomography | 2004 |
Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Topics: Acetylcysteine; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Free Radical Scavengers; Male; Methamphetamine; Neurotoxicity Syndromes; Rats; Time Factors | 2004 |
Effects of N-acetyl-L-cysteine on the reduction of brain dopamine transporters in monkey treated with methamphetamine.
Topics: Acetylcysteine; Animals; Antioxidants; Dopamine Plasma Membrane Transport Proteins; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins | 2004 |
Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Topics: Acetylcysteine; Animals; Behavior, Animal; Brain Chemistry; Cocaine; Conditioning, Operant; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Free Radical Scavengers; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutathione; Learning Disabilities; Male; Methamphetamine; Mice; Neurotoxicity Syndromes; Tyrosine 3-Monooxygenase | 2007 |
N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells.
Topics: Acetylcysteine; Brain; Cell Line, Transformed; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; Methamphetamine; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species | 2009 |
HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.
Topics: Acetylcysteine; AIDS Dementia Complex; Animals; Antioxidants; Blood-Brain Barrier; Brain; Glutathione Disulfide; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Illicit Drugs; Malondialdehyde; Methamphetamine; Mice; Mice, Inbred Strains; Oxidative Stress; Risk Factors; tat Gene Products, Human Immunodeficiency Virus; Tight Junctions | 2010 |
Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.
Topics: Acetylcysteine; Adrenergic Uptake Inhibitors; Animals; Brain; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotoxins; Rats; Rats, Sprague-Dawley; Serotonin | 2011 |
N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Catalase; Central Nervous System Stimulants; Glutathione; Glutathione Peroxidase; Kidney; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methamphetamine; Mice; Oxidative Stress; Protein Carbonylation | 2012 |
A potential role for N-acetylcysteine in the management of methamphetamine dependence.
Topics: Acetylcysteine; Amphetamine-Related Disorders; Antioxidants; Australia; Brain; Glutamic Acid; Humans; Methamphetamine | 2017 |
Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity.
Topics: Acetylcysteine; Amphetamines; Apoptosis; Autophagy; Benzodioxoles; Cell Line; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Dose-Response Relationship, Drug; Humans; Methamphetamine; Microtubule-Associated Proteins; Neurotoxicity Syndromes; Oxidative Stress; Pyrrolidines; Synthetic Cathinone | 2017 |
The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats.
Topics: Acetylcysteine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Estrous Cycle; Female; Methamphetamine; Motor Activity; Psychotropic Drugs; Rats, Sprague-Dawley; Self Administration | 2018 |
HIV-1 Tat and methamphetamine co-induced oxidative cellular injury is mitigated by N-acetylcysteine amide (NACA) through rectifying mTOR signaling.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Methamphetamine; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; tat Gene Products, Human Immunodeficiency Virus; TOR Serine-Threonine Kinases | 2018 |